Webinar

The effect of probiotics on gastrointestinal symptoms in adults, a clinical study

19 MAY 2020 Tuesday

Format: External webinar | Document type: Webinar

As consumer awareness and interest around the probiotic space continues to grow, probiotic manufacturers must focus on clinical research to support their offerings. UAS Labs has been investing in research for over 40 years and recently completed one of the world’s largest probiotic-digestive health studies. Join Chief Scientific Officer, Dr. Greg Leyer, as he shares the results of a study which used a unique, parallel-arm design to assess the effect of Lactobacillus and Bifidobacterium strains on problematic gastrointestinal symptoms in over 300 subjects.

Speakers

Dr. Greg Leyer Chief Scientific Officer
UAS Labs

Kevin Mehring President / CEO
UAS Labs

Latest content from UAS Laboratories

Content provided by UAS Laboratories

L. Plantarum PPLP-217: Planting Seeds for a Healthy Life

Neonates and infants can benefit tremendously from consuming Lactobacillus plantarum PPLP-217, and products carrying this strain will help promote infant well-being worldwide.

Content provided by UAS Laboratories

BNR17: A clinically-validated weight management probiotic in tune with healthy eating trends

The world has a serious obesity problem. From the Americas to Zimbabwe, a fast-rising proportion of people are classed as obese or overweight. People initially sought out diets to bring their waistlines under control but increasingly are shunning these...

Content provided by UAS Laboratories

UAS Labs: A multi-decade legacy of research defined by three superstrains

UAS Labs has been at the forefront of probiotic research for almost 40 years. Since opening its doors in 1979, the pure-play probiotic specialist has developed a series of strains that have moved the field beyond its roots and into the emerging era of...